Two studies have found the omicron booster to be lacking when it comes to its strength against new COVID-19 subvariants BQ.1.1, XBB and BA.2.75.2 — which, together, account for 38 percent of cases.
Read the full post on Becker's Hospital Review - Healthcare News
